Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4+ cell counts in gaborone, Botswana

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 1, 2010, Pages 102-106

  Chen, Jennifer Y ^a   Ogwu, Anthony C ^b   Svab, Petr ^c   Lockman, Shahin ^d,e   Moffat, Howard J ^f   Gaolathe, Tendani ^g   Moilwa, Shana ^c   Størdal, Ketil ^c   Dryden Peterson, Scott ^a,h   Moffat, Claire ^b   Makhema, Joseph ^b   Essex, M ^e   Shapiro, Roger L ^e,i  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^c PRINCESS MARINA HOSPITAL   (Botswana)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f Department of HIV AIDS Prevention and Care   (Botswana)

^g Botswana Harvard PEPFAR Master Trainer Program   (Botswana)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Botswana; CD4+ cell count testing; HAART initiation

Indexed keywords

ZIDOVUDINE;

ADULT; ARTICLE; BOTSWANA; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT REFERRAL; PATIENT SELECTION; PRACTICE GUIDELINE; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; BOTSWANA; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; YOUNG ADULT;

EID: 77951675368     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181c080bf     Document Type: Article

References (24)

1. Gilks C. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Towards Universal Access. In: HIV/AIDS Programme WHO. Geneva Switzerland: WHO Press 2006.
2. Kuhn L, Aldrovandi GM, Sinkala M, et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med. 2008; 359:130-141.
3. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA. 2006;296: 794-805.
4. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802.
5. Nakabiito C, Guay LA, Musoke P, et al. Effect of Nevirapine (NVP) for perinatal HIV prevention appears strong among women with advanced disease: subgroup analyses of HIVNET 012. Presented at: International Conference on AIDS; July 2002; Barcelona, Spain.
6. Leroy V, Sakarovitch C, Cortina-Borja M, et al. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS. 2005;19:1865-1875.
7. Inter-agency Task Team on Prevention of HIV Infection in Pregnant Women M, and their Children. Guidance on Global Scale-Up of the Prevention of Mother-to-Child Transmission of HIV. Geneva, Switzerland: WHO Press 2007
8. Agency NAC. 2008 Progress Report of the National Response to the UNGASS Declaration of Committment on HIV/AIDS. Gaborone, Botswana: Ministry of State President RoB; 2008.
9. Agency NAC. Botswana AIDS Impact Survey II: Popular Report. Gaborone, Botswana: UN; 2005.
10. Creek TL, Ntumy R, Seipone K, et al. Successful introduction of routine opt-out HIV testing in antenatal care in Botswana. J Acquir Immune Defic Syndr. 2007;45:102-107.
11. Puvimanasinghe JPA, Ndwapi N, Gaolathe T, et al. Six years of HAART in the public sector of Botswana. Presented at: International AIDS Conference; August 2008; Mexico City, Mexico.
12. Division HAIM. HAART Patient Update Summary. Gaborone, Botswana: Unit MaE; 2008.
13. Gadathe T. Botswana 2008 National HIV/AIDS Guidelines. Gaborone, Botswana: Botswana Ministry of Health; 2008.
14. Botswana Ministry of Health. Botswana National ARV Guidelines. Gaborone, Botswana: Botswana Ministry of Health 2005.
15. Tlale J KK, Anderson MG, et al. Mother-to-child HIV transmission rate in Botswana\analysis of dried blood spot (DBS) results from the national PMTCT programme. Presented at: International AIDS Conference; August 2008; Mexico City, Mexico.
16. Ekouevi DK, Coffie PA, Becquet R, et al. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Cote d'Ivoire. AIDS. 2008;22:1815-1820.
17. Taha TE, Kumwenda J, Cole S, et al. Effect of maternal HAART on postnatal HIV-1 transmission after cessation of extended infant ARV prophylaxis. Presented at: 16th Conference on Retroviruses and Opportunistic Infections; February 2009; Montreal, Canada.
18. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med. 1999;341:385-393.
19. Dabis F, Bequet L, Ekouevi DK, et al. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS. 2005;19:309-318.
20. Frenkel LM, Cowles MK, Shapiro DE, et al. Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1. J Infect Dis. 1997;175:971-974.
21. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351:217-228.
22. Simpson BJ, Shapiro ED, Andiman WA. Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:145-152.
23. Creek T, Ntumy R, Mazhani L, et al. Factors associated with low early uptake of a national program to prevent mother to child transmission of HIV (PMTCT): results of a survey of mothers and providers, Botswana, 2003. AIDS Behav. 2009;13:356-364.
24. Lu L, Legwaila K, Motswere C, et al. HIV Incidence in pregnancy and the first post-partum year and implications for PMTCT Programs, Francistown, Botswana, 2008. Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada.